Related Experiment Videos
Ureteropelvic junction disease.
Luigi Perrelli1, Santiago Vallasciani
1Divisione di Chirurgia Pediatrica, Università Cattolica del S. Cuore, Policlinico A. Gemelli, Largo A. Gemelli 8, 00168, Roma, Italy. chirurgia.pediatrica@m.unicatt.it
Summary
Ureteropelvic junction disease, a common congenital anomaly causing hydronephrosis, requires careful management based on symptoms. Asymptomatic cases necessitate close monitoring to prevent kidney damage, while symptomatic patients often benefit from Anderson-Hynes pyeloplasty.
Area of Science:
- Urology
- Pediatric Urology
- Congenital Anomalies
Background:
- Ureteropelvic junction disease is a frequent congenital urological anomaly causing hydronephrosis.
- It results from congenital abnormalities in the ureteropelvic junction, potentially linked to embryonic developmental errors.
- Over a third of affected individuals present with associated uropathy.
Purpose of the Study:
- To review the definition, etiology, and clinical presentation of ureteropelvic junction disease.
- To discuss current management strategies, particularly for asymptomatic cases identified through neonatal screening.
- To highlight the importance of follow-up and surgical indications.
Main Methods:
- Review of existing literature on ureteropelvic junction disease.
- Analysis of diagnostic approaches, including sonography.
- Evaluation of treatment outcomes for both conservative and surgical management.
Main Results:
- Neonatal sonography has increased the detection of asymptomatic ureteropelvic junction disease.
- Management decisions are primarily guided by clinical presentation (symptomatic vs. asymptomatic).
- Anderson-Hynes pyeloplasty remains the standard surgical treatment when indicated.
Conclusions:
- Careful follow-up is crucial for asymptomatic patients to prevent renal function decline.
- Symptomatic ureteropelvic junction disease requires surgical intervention.
- Understanding the etiology and presentation is key to optimizing patient outcomes.